Answers are grounded in this paper and cite their sources.
This article reviews the most recent literature describing clinical advances in adoptive cell therapy for patients with head and neck cancer. Clinical trials with tumor-infiltrating lymphocyte and gene-engineered T-cell receptor T-cell therapy are highlighted.
No takes yet. Share an insight, caveat, or question.
Norberg et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: